Alberto de la Fuente

Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity—Opportunity for Repurposed Chemotherapy of COVID-19 Infection

Maryam Al-Motawa, Hafsa Abbas, Patrick Wijten et al. · Frontiers in Pharmacology · 2020 · 31 citations · Full text

Life Sciences, Biochemistry, Infectious Diseases +17

Studies of Glyoxalase 1-Linked Multidrug Resistance Reveal Glycolysis-Derived Reactive Metabolite, Methylglyoxal, Is a Common Contributor in Cancer Chemotherapy Targeting the Spliceosome

Muhanad Alhujaily, Hafsa Abbas, Mingzhan Xue et al. · Frontiers in Oncology · 2021 · 31 citations · Full text

Medicine, Oncology, Pharmacology +17

Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in Dementia

Hanan Ehtewish, Areej G. Mesleh, Georgios Ponirakis et al. · International Journal of Molecular Sciences · 2023 · 30 citations · Full text

Life Sciences, Biochemistry, Neurology +17

Vulnerabilities of the SARS-CoV-2 virus to proteotoxicity – opportunity for repurposed chemotherapy of COVID-19 infection

Maryam Al-Motawa, Hafsa Abbas, Patrick Wijten et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 15 citations · Full text

Life Sciences, Biochemistry, Infectious Diseases +17

Deletion of TRPC6, an Autism Risk Gene, Induces Hyperexcitability in Cortical Neurons Derived from Human Pluripotent Stem Cells

Kyung Chul Shin, Gowher Ali, Houda Yasmine Ali Moussa et al. · Molecular Neurobiology · 2023 · 15 citations · Full text

Life Sciences, Genetics, Neuroscience +17